Related news from
Thu, 26 Mar 2026 14:57:21 +0000	Reflecting On Health Insurance Providers Stocks’ Q4 Earnings: Cencora (NYSE:COR) As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at health insurance providers stocks, starting with Cencora (NYSE:COR).
Wed, 25 Mar 2026 02:34:22 +0000	Why STAAR Surgical (STAA) Stock Is Trading Up Today Shares of medical lens company STAAR Surgical (NASDAQ:STAA) jumped 3.7% in the afternoon session after investors reacted to positive news in the broader ophthalmology sector as Cencora agreed to acquire EyeSouth Partners' retina business for $1.1 billion.
Tue, 24 Mar 2026 14:21:00 +0000	COR to Expand Retina Consultants of America With $1.1B EyeSouth Deal Cencora is acquiring EyeSouth's retina business for $1.1 billion, expanding its RCA platform to strengthen foothold in the fast-growing eye care market.
Tue, 24 Mar 2026 12:15:00 +0000	Kultura Brands (OTC:LTNC) Accelerates National Momentum With Cencora Marketplace Spring & Summer Growth Acceleration Program JACKSON, WY / ACCESS Newswire / March 24, 2026 / Kultura Brands Inc., formerly known as Labor Smart INC. (OTCID:LTNC), a rapidly emerging platform focused on high-growth beverage and functional wellness brands, today announced its expanded participation ...
Tue, 24 Mar 2026 09:19:42 +0000	Cencora to buy EyeSouth’s retina business for $1.1B The proposed acquisition is Cencora’s latest push into retina services as the company looks to expand its specialty support business. Cencora doesn't expect the deal to close before the end of September.
Mon, 23 Mar 2026 20:47:11 +0000	Wall Street Snaps 3-Day Losing Streak, Oil Retreats as Trump Postpones Strikes on Iran US equities rallied Monday after three straight sessions of losses, while oil prices slid as Preside
Mon, 23 Mar 2026 19:54:59 +0000	Sector Update: Health Care Stocks Advance Late Afternoon Health care stocks rose late Monday afternoon with the NYSE Health Care Index up 0.5% and the State
Mon, 23 Mar 2026 18:13:45 +0000	Equities Rise Intraday, Oil Plunges as Trump Delays Strikes on Iranian Energy Infrastructure US benchmark equity indexes were higher intraday, while oil prices tumbled after President Donald Tr
Mon, 23 Mar 2026 17:14:29 +0000	US Equity Indexes Jump, Crude Oil Slides as Trump Offers 5-Day Reprieve to Iran Amid 'Productive' Talks US equity indexes jumped in midday trading Monday as President Donald Trump's move to postpone a pla
Mon, 23 Mar 2026 16:04:00 +0000	Active ETFs Surge Past Passive, and These Are in the Lead Actively managed ETFs have become increasingly popular among investors willing to pay a premium for flexibility, star managers, and sophisticated strategies.
Mon, 23 Mar 2026 13:39:11 +0000	Cencora to Acquire EyeSouth Partners' Retina Business in $1.1 Billion Deal Cencora (COR) said Monday that it will acquire EyeSouth Partners' retina business for $1.1 billion a
Mon, 23 Mar 2026 11:00:00 +0000	Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business CONSHOHOCKEN, Pa., March 23, 2026--Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of EyeSouth Partners will join Cencora’s Retina Consultants of America ("RCA"), a leading management services organization (MSO).
Sun, 22 Mar 2026 16:05:06 +0000	Cencora CFO Retirement Puts Capital Allocation And Growth Plans In Focus Cencora (NYSE:COR) announced the planned retirement of Chief Financial Officer and Executive Vice President James F. Cleary. The company has begun a leadership transition process and initiated an executive search to identify his successor. Cleary’s retirement marks the end of a long tenure in the CFO role and a significant change in Cencora’s senior leadership team. Cencora, a major player in pharmaceutical distribution and related services, sits at the center of global drug supply chains,...
Fri, 20 Mar 2026 13:25:05 +0000	Here’s Why Cencora (COR) Shares Rose 8% in Q4 TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The strategy returned -3.55% (gross) and -3.76% (net) in the fourth quarter compared to a -3.70% return for the Russell Midcap Growth Index. In 2025, the strategy returned 14.84% […]
Wed, 18 Mar 2026 11:13:35 +0000	1 Healthcare Stock with Exciting Potential and 2 We Ignore From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 3.6% over the past six months, topping the S&P 500 by 2.3 percentage points.
Tue, 17 Mar 2026 17:06:00 +0000	Here's Why You Should Hold Cencora Stock in Your Portfolio for Now Cencora's strong U.S. growth, MSO strategy, and raised outlook support long-term potential, but competition and customer losses remain key risks.
Tue, 17 Mar 2026 12:30:00 +0000	Cencora Announces Financial Leadership Transition CONSHOHOCKEN, Pa., March 17, 2026--Cencora, Inc. (NYSE: COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has engaged an executive search firm to identify and evaluate potential successors from internal and external candidates. Mr. Cleary will assist in the search process and will serve in an advisory capacity through the end of 2026 to help ensure a smooth transition.
Tue, 17 Mar 2026 09:32:18 +0000	Cencora CFO announces retirement James Cleary will step down from the post on June 30, but stay on as an adviser to the company through the end of the year. He’s the second finance chief of a drug distributor to announce their retirement this month.
Fri, 13 Mar 2026 17:07:11 +0000	How Cardinal Health, The IBD Stock Of The Day, Is Navigating The Tricky Macro Cardinal Health is Friday's IBD Stock Of The Day. Shares are in a buy zone as the medical wholesaler easily navigates macro challenges.
Fri, 13 Mar 2026 15:30:05 +0000	Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report? Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!